Abstract
Cutaneous melanoma of the eyelid is a rare tumor, representing fewer than 1 % of all malignant neoplasms of the eyelid skin [1], 1 % of all skin melanomas [2], and 7 % of cutaneous malignant melanomas of the head and neck region [3]. Many primary melanomas of the eyelid involve the mucosal surfaces of the palpebral and bulbar conjunctiva, and in these cases, one must manage not only the eyelid but also the conjunctival component of the lesion. One may argue reasonably that primary conjunctival melanomas may affect the eyelid secondarily.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cook Jr BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–100.
Rodriguez-Sains RS, Jakobiec FA, Iwamoto T. Lentigo maligna of the lateral canthal skin. Ophthalmology. 1981;88(12):1186–92.
Batsakis J. Tumors of the head and neck. Baltimore: Williams and Wilkins; 1974.
Naidoff MA, Bernardino VB, Clark WH. Melanocytic lesions of the eyelid skin. Am J Ophthalmol. 1976;82(3):371–82.
Garner A, Koornneef L, Levene A, et al. Malignant melanoma of the eyelid skin: histopathology and behaviour. Br J Ophthalmol. 1985;69(3):180–6.
Zoltie N, O’Neill TJ. Malignant melanomas of eyelid skin. Plast Reconstr Surg. 1989;83(6):994–6.
Grossniklaus HE, McLean IW. Cutaneous melanoma of the eyelid. Clinicopathologic features. Ophthalmology. 1991;98(12):1867–73.
Tahery DP, Goldberg R, Moy RL. Malignant melanoma of the eyelid. A report of eight cases and a review of the literature. J Am Acad Dermatol. 1992;27(1):17–21.
Vaziri M, Buffam FV, Martinka M, et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology. 2002;109(5):901–8.
Chan FM, O’Donnell BA, Whitehead K, et al. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007;114(1):187–92.
Wang JK, Liao SL, Jou JR, et al. Malignant eyelid tumours in Taiwan. Eye. 2003;17(2):216–20.
Takamura H, Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata University Hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol. 2005;49(5):349–54.
Then SY, Malhotra R, Barlow R, et al. Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma. Dermatol Surg. 2009;35(1):17–23.
Kostopoulos E, Champsas G, Konofaos P, et al. Eyelid melanoma: our experience a propos of 23 cases. Ann Chir Plast Esthet. 2012;57(2):158–63.
Patel BC, Egan CA, Lucius RW, et al. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol. 1998;38(5 Pt 2):862–5.
Demirci H, Johnson TM, Frueh BR, et al. Management of periocular cutaneous melanoma with a staged excision technique and permanent sections: the square procedure. Ophthalmology. 2008;115(12):2295–300.
Clark Jr WH, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29(3):705–27.
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.
Harris MN, Shapiro RL, Roses DF. Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging. Cancer. 1995;75(2 Suppl):715–25.
Malhotra R, Chen C, Huilgol S, et al. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology. 2003;110(10):2011–8.
Boulos PR, Rubin PA. Cutaneous melanomas of the eyelid. Semin Ophthalmol. 2006;21(3):195–206.
Esmaeli B, Youssef A, Naderi A, et al. for the Collaborative Eyelid Skin Melanoma Group. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group report. Ophthal Plast Reconstr Surg. 2003; 19(2):96–101.
Glat P, Longaker M, Jelks EB, et al. Periorbital melanocytic lesions: excision and reconstruction in 40 patients. Plast Reconstr Surg. 1998;102(1):19–27.
Stanowsky A, Krey HF, Kopp J, et al. Irradiation of malignant eyelid melanoma with Iodine-125 plaque. Am J Ophthalmol. 1990;110(1):44–8.
Shiose S, Sakamoto T, Yoshikawa H, et al. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Invest Ophthalmol Vis Sci. 2000;41(9):2395–403.
Savar A, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology. 2009;116(11):2217–23.
Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg. 2000;16(4):250–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pe’er, J., Folberg, R. (2014). Eyelid Tumors: Cutaneous Melanoma. In: Pe'er, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38336-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-38336-6_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38335-9
Online ISBN: 978-3-642-38336-6
eBook Packages: MedicineMedicine (R0)